KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vir Biotechnology (VIR) Interest & Investment Income (2018 - 2025)

Vir Biotechnology's Interest & Investment Income history spans 6 years, with the latest figure at $7.8 million for Q4 2025.

  • For Q4 2025, Interest & Investment Income fell 44.87% year-over-year to $7.8 million; the TTM value through Dec 2025 reached $40.2 million, down 43.97%, while the annual FY2025 figure was $40.2 million, 43.97% down from the prior year.
  • Interest & Investment Income for Q4 2025 was $7.8 million at Vir Biotechnology, down from $9.4 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $21.9 million in Q3 2023 and bottomed at $7.8 million in Q4 2025.
  • The 3-year median for Interest & Investment Income is $14.2 million (2024), against an average of $14.9 million.
  • The largest annual shift saw Interest & Investment Income decreased 20.08% in 2024 before it tumbled 46.58% in 2025.
  • A 3-year view of Interest & Investment Income shows it stood at $21.9 million in 2023, then plummeted by 35.47% to $14.2 million in 2024, then plummeted by 44.87% to $7.8 million in 2025.
  • Per Business Quant, the three most recent readings for VIR's Interest & Investment Income are $7.8 million (Q4 2025), $9.4 million (Q3 2025), and $10.8 million (Q2 2025).